Researchers design bone marrow-on-a-chip model to study human immune cells - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Development of a Bone Marrow-on-a-Chip System for Investigating Human Immune Cell Dynamics

  • September 11, 2026

Share

Clinical Report: Development of a Bone Marrow-on-a-Chip System for Investigating Human Immune Cell Dynamics

Overview

A novel bone marrow-on-a-chip model has been developed to study the dynamics of human immune cells, particularly long-lived plasma cells. This NIH-funded research provides insights into plasma cell migration, maturation, and persistence in bone marrow.

Background

Understanding the behavior of plasma cells in the human immune system is essential for developing therapies against infections, allergies, and autoimmune diseases. Long-lived plasma cells are crucial for maintaining antibody production and durable immunity. However, the mechanisms governing their migration and maintenance in bone marrow are not well understood.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • The bone marrow-on-a-chip model integrates a lymphoid organoid and a tissue chip to study plasma cell dynamics.
  • This platform allows for the observation of plasma cell migration, maturation, and persistence in a controlled environment.
  • High-resolution imaging of plasma cells within the chip enables the interpretation of their activity in response to signaling proteins.
  • Research addresses fundamental questions regarding B cell migration from lymphoid organs to bone marrow.

Clinical Implications

The bone marrow-on-a-chip model provides a platform for studying human immune cell behavior.

Conclusion

This model represents a significant advancement in the study of human immune cell dynamics.

Related Resources & Content

  1. NIH, Science Advances, 2026 -- Development of a Bone Marrow-on-a-Chip System for Investigating Human Immune Cell Dynamics
  2. the asco post — Preclinical Leukemia Chip Platform Improves Evaluation of CAR T-Cell Therapies
  3. the medicine maker — Breaking New Ground in IBD Research with Organ-Chips
  4. the analytical scientist — Chip Off the Old Block
  5. Frontiers in Immunology — Microfluidic chips for decoding cancer-immune crosstalk in immunotherapy
  6. Preclinical Leukemia Chip Platform Improves Evaluation of CAR T-Cell Therapies
  7. Breaking New Ground in IBD Research with Organ-Chips
  8. Chip Off the Old Block
  9. Microfluidic chips for decoding cancer-immune crosstalk in immunotherapy
  10. Intermittent fasting evicts long-lived plasma cells from survival niche | Nature Reviews Immunology
  11. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older
  12. A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection | New England Journal of Medicine

Original Source(s)

Related Content